Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
J Gen Virol
    April 2024
  1. ZHANG J, Cui L, Zhang Y, Pan H, et al
    Oral administration of PEDV-dissolved Alg-CS gel induces high and sustained mucosal immunity in mice.
    J Gen Virol. 2024;105.
    >> Share

    March 2024
  2. BAI W, Zhu Q, Wang J, Jiang L, et al
    Licorice extract inhibits porcine epidemic diarrhea virus in vitro and in vivo.
    J Gen Virol. 2024;105.
    >> Share

  3. SAMOLEJ J, White IJ, Strang BL, Mercer J, et al
    Cardiac glycosides inhibit early and late vaccinia virus protein expression.
    J Gen Virol. 2024;105.
    >> Share

    February 2024
  4. RAO S, Erku D, Mahalingam S, Taylor A, et al
    Immunogenicity, safety and duration of protection afforded by chikungunya virus vaccines undergoing human clinical trials.
    J Gen Virol. 2024;105.
    >> Share

    January 2024
  5. MCMILLAN CLD, Wijesundara DK, Choo JJY, Amarilla AA, et al
    Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein.
    J Gen Virol. 2024;105.
    >> Share

    December 2023
  6. ALMASOUD I, Charlton FW, Finke S, Barr JN, et al
    Internalization of rabies virus glycoprotein differs between pathogenic and attenuated virus strains.
    J Gen Virol. 2023;104.
    >> Share

    November 2023
  7. DELHON G, Khatiwada S, Doub D, Harris S, et al
    Bovine papular stomatitis virus as a vaccine vector for cattle.
    J Gen Virol. 2023;104.
    >> Share

    August 2023
  8. CHA SH, Hyun BH, Lee HS, Kang SJ, et al
    A novel chimeric vaccine candidate for porcine reproductive and respiratory syndrome virus (PRRSV) I and II elicits neutralizing antibodies against both types.
    J Gen Virol. 2023;104.
    >> Share

    June 2023
  9. GOMES AC, Baraniak IA, McIntosh MR, Sodi I, et al
    A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' sera.
    J Gen Virol. 2023;104.
    >> Share

  10. KINGSTON NJ, Snowden JS, Martyna A, Shegdar M, et al
    Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.
    J Gen Virol. 2023;104.
    >> Share

    May 2023
  11. SULLIVAN DJ, Franchini M, Senefeld JW, Joyner MJ, et al
    Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1.
    J Gen Virol. 2023;104.
    >> Share

  12. LI S, Li J, Tian Y, Liu J, et al
    A potent CD8 T-cell response may be associated with partial cross-protection conferred by an attenuated Chinese HP-PRRSV vaccine against NADC30-like PRRSV challenge.
    J Gen Virol. 2023;104.
    >> Share

  13. DE BUHR H, de Leeuw OS, Harders F, Peeters BP, et al
    Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus.
    J Gen Virol. 2023;104.
    >> Share

    April 2023
  14. VAZ PK, Armat M, Hartley CA, Devlin JM, et al
    Codon pair bias deoptimization of essential genes in infectious laryngotracheitis virus reduces protein expression.
    J Gen Virol. 2023;104.
    >> Share

    March 2023
  15. PINTADO SILVA J, Fernandez-Sesma A
    Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art.
    J Gen Virol. 2023;104.
    >> Share

    February 2023
  16. SCHMITZ KS, Eble PL, van Gennip RGP, Maris-Veldhuis MA, et al
    Pathogenesis of wild-type- and vaccine-based recombinant peste des petits ruminants virus (PPRV) expressing EGFP in experimentally infected domestic goats.
    J Gen Virol. 2023;104.
    >> Share

    November 2022
  17. DEMPSEY R, Ritter L, Parker L
    Strain development of A/H1N1pdm09 candidate vaccine viruses for the 2021-22 northern hemisphere influenza season.
    J Gen Virol. 2022;103.
    >> Share

  18. SHMELEVA EV, Syafiq D, Moldoveanu AL, Ferguson BJ, et al
    Suppression of innate immunity by the vaccinia virus protein N1 promotes skin microbiota expansion and increased immune infiltration following vaccination.
    J Gen Virol. 2022;103.
    >> Share

    October 2022
  19. ZHANG RY, Pallett MA, French J, Ren H, et al
    Vaccinia virus BTB-Kelch proteins C2 and F3 inhibit NF-kappaB activation.
    J Gen Virol. 2022;103.
    >> Share

    July 2022
  20. SHARTOUNY JR, Lowen AC
    Message in a bottle: mRNA vaccination for influenza.
    J Gen Virol. 2022;103.
    >> Share

  21. SEESEN M, Jearanaiwitayakul T, Limthongkul J, Sunintaboon P, et al
    Mice immunized with trimethyl chitosan nanoparticles containing DENV-2 envelope domain III elicit neutralizing antibodies with undetectable antibody-dependent enhancement activity.
    J Gen Virol. 2022;103.
    >> Share

    June 2022
  22. ELBEHAIRY MA, Samal SK, Belov GA
    Encoding of a transgene in-frame with a Newcastle disease virus protein increases transgene expression and stability.
    J Gen Virol. 2022;103.
    >> Share

    January 2022
  23. GAO WND, Gao C, Deane JE, Carpentier DCJ, et al
    The crystal structure of vaccinia virus protein E2 and perspectives on the prediction of novel viral protein folds.
    J Gen Virol. 2022;103.
    >> Share

  24. PIADEL K, Haybatollahi A, Dalgleish AG, Smith PL, et al
    Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.
    J Gen Virol. 2022;103.
    >> Share

    October 2021
  25. WANG C, Lv L, Wu Q, Wang Z, et al
    The role of interferon regulatory factor 7 in the pathogenicity and immunogenicity of rabies virus in a mouse model.
    J Gen Virol. 2021;102.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016